Related Experiment Videos
Elastin degradation in systemic vasculitis
M Bokarewa1, A Baranov, E Nassonov
1Department of Rheumatology, Moscow Medical Academy, Russia.
Insights
This study investigated elastin peptide (EP) and elastase activity (EA) in vasculitis patients. Lower EP and EA were found in thromboangiitis obliterans, suggesting distinct vascular damage mechanisms compared to atherosclerosis.
Area of Science:
- Biochemistry
- Immunology
- Vascular Biology
Background:
- Systemic vasculitis encompasses diverse inflammatory conditions affecting blood vessels.
- Elastin degradation is implicated in vascular pathology, but its role varies across vasculitis types.
- Quantifying elastin peptides (EP) and elastase activity (EA) may differentiate vascular damage mechanisms.
Purpose of the Study:
- To compare EP and EA levels in patients with different systemic vasculitides and controls.
- To investigate potential differences in elastin degradation pathways between vasculitis and atherosclerosis.
- To assess the impact of corticosteroid treatment on EP and EA levels.
Main Methods:
- Measured EP and EA in 89 patients with polyarteritis nodosa, non-specific aortoarteritis, temporal arteritis, and thromboangiitis obliterans.
- Included control groups of 31 patients with leg atherosclerosis and 12 healthy aged subjects.
- Analyzed EP and EA levels before and after corticosteroid treatment where applicable.
Main Results:
- Thromboangiitis obliterans patients showed significantly lower EP and EA compared to atherosclerosis and aged controls.
- Giant-cell arteritis (temporal arteritis) exhibited increased EP and the lowest EA among vasculitis groups.
- Corticosteroid treatment correlated with increased EP in temporal arteritis and increased EA in thromboangiitis obliterans.
Conclusions:
- EP and EA levels may help distinguish between atherosclerosis and inflammatory vascular diseases.
- Distinct elastin degradation patterns exist across different systemic vasculitides.
- Elastin degradation markers can reflect treatment response in specific vasculitis types.
Abstract:
The elastin peptide level (EP) and elastase-type activity (EA) were investigated in 89 patients with different types of systemic vasculitis (polyarteritis nodosa-14, non-specific aortoarteritis-33, temporal arteritis-23 and thromboangiitis obliterans-18) and compared to the controls: 31 patients with leg atherosclerosis and 12 aged subjects with no evident vascular pathology. EP and EA levels in patients with thromboangiitis obliterans were significantly lower as compared to leg atherosclerosis and the aged control group (p < 0.02 for EA, p < 0.05 for EP). The increase of EP predominated in giant-cell arteritis as compared to the other vasculitic groups (18/56 vs. 5/32, p < 0.05); EA in these patients was the lowest. The activation of elastin degradation after corticosteroid treatment was demonstrated by an increase of EP in temporal arteritis (p < 0.05) and of EA in thromboangiitis obliterans (p < 0.03). We suggest that the determination of the above parameters of elastin degradation may be helpful in the search for differences in mechanisms of vascular damage between atherosclerosis and inflammatory vascular diseases.